RIV Capital (OTC: CNPO.F)
Some price data may be temporarily unavailable.
Key Data Points
RIV Capital Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
RIV Capital Company Info
RIV Capital, Inc. is an investment and operating platform structured to pursue opportunities in the global cannabis sector. It identifies strategic counterparties seeking financial and/or operating support. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. It provides with opportunities to work with Canopy Growth and collaborate among themselves. Canopy Rivers was founded by Sean McNulty and Peter Hatziioannou on October 31, 2017 and is headquartered in Toronto, ON.
News & Analysis
What You'll Want to Know About Canopy Rivers' Q1 Results
The cannabis investment company reported improvements in its top and bottom lines in the first quarter.
Better Cannabis Stock: Canopy Rivers vs. Innovative Industrial Properties
Which stock wins in a face-off between an investment spin-off of a leading Canadian cannabis producer and the top U.S. cannabis-focused REIT?
10 Marijuana Stocks Wall Street Thinks Will Double
With up to 196% upside, should these cannabis stocks be in your portfolio?
The 2 Pot Stocks Former Canopy Growth Co-CEO Bruce Linton Thinks You Should Buy
No longer constrained by role as co-CEO, Linton handpicked these two marijuana stocks as possible investments.
Looking for Pot Stock Tips? Canopy Growth's Ex-CEO Just Gave 3 of Them
Bruce Linton is out as Canopy Growth's CEO. But he has some ideas on which cannabis stocks investors should consider buying.
These Worst-Performing Pot Stocks Fell at Least 20% in March
There are some very familiar marijuana stocks among this bunch of losers.
These 5 Pot Stocks Lost 16% (or More) in February
The green rush came to an abrupt end for these marijuana stocks last month.
Better Marijuana Stock: Aurora Cannabis vs. Canopy Rivers
Which stock wins in a matchup between a top Canadian marijuana producer and a spinoff of one of its key rivals?
Financial Health
General
Q3 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q3 2024 | YoY Change |
---|
Liabilities
Q3 2024 | YoY Change |
---|
Ratios
Q3 2024 | YoY Change |
---|
Cash Flow
Q3 2024 | YoY Change |
---|
Valuation
Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.